
For approval of a generic drug product, the assessment of zzso in drug zzso is usually considered as a surrogate for evaluation of drug efficacy and safety in clinical zzso For some drug products, the United States Food and Drug Administration indicates that the assessment of similarity between dissolution profiles may be used as a surrogate for assessment of zzso Along this line, we propose assessing zzso using zzso data collected from the same individuals, assuming that there is an established relationship between zzso and zzso zzso Because there may be a bias in the prediction of zzso data using zzso data and the variations in these two types of data are different, we propose to assess zzso based on sensitivity analysis of prediction bias and variation difference within some predetermined zzso Our methods are derived for average, population, and individual zzso 

